STE – Steris Plc
STE — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
1.8
Margin Of Safety %
18
Put/Call OI Ratio
0.38
EPS Next Q Diff
-0.02
EPS Last/This Y
3.96
EPS This/Next Y
0.9
Price
219.42
Target Price
287.33
Analyst Recom
1.8
Performance Q
-14.19
Upside
-27.5%
Beta
1.07
Ticker: STE
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | STE | 252.28 | 1.91 | 0.00 | 1857 |
| 2026-03-02 | STE | 247.81 | 1.91 | 999.99 | 1857 |
| 2026-03-03 | STE | 243.38 | 1.91 | 999.99 | 1857 |
| 2026-03-04 | STE | 243.11 | 1.91 | 999.99 | 1857 |
| 2026-03-05 | STE | 238.32 | 1.68 | 780.00 | 1711 |
| 2026-03-06 | STE | 230.46 | 1.56 | 4.40 | 1641 |
| 2026-03-09 | STE | 227.61 | 1.52 | 999.99 | 1622 |
| 2026-03-10 | STE | 222.07 | 1.52 | 460.00 | 1615 |
| 2026-03-11 | STE | 221.51 | 2.10 | 1.56 | 1995 |
| 2026-03-12 | STE | 212.36 | 0.97 | 999.99 | 1280 |
| 2026-03-13 | STE | 212.35 | 0.97 | 739.00 | 1280 |
| 2026-03-17 | STE | 220.31 | 1.12 | 0.00 | 1547 |
| 2026-03-18 | STE | 216.16 | 1.12 | 0.00 | 1547 |
| 2026-03-19 | STE | 217.97 | 1.11 | 0.00 | 1542 |
| 2026-03-20 | STE | 220.17 | 0.85 | 0.00 | 1603 |
| 2026-03-23 | STE | 221.07 | 0.39 | 2.29 | 704 |
| 2026-03-24 | STE | 221.72 | 0.44 | 0.10 | 928 |
| 2026-03-25 | STE | 223.4 | 0.38 | 0.00 | 1005 |
| 2026-03-26 | STE | 223.43 | 0.36 | 0.47 | 1042 |
| 2026-03-27 | STE | 219.51 | 0.38 | 1.00 | 1045 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | STE | 252.26 | 4.0 | 204.6 | 10.20 |
| 2026-03-02 | STE | 247.72 | 4.0 | 165.7 | 10.20 |
| 2026-03-03 | STE | 243.26 | 4.0 | 165.8 | 10.20 |
| 2026-03-04 | STE | 243.09 | 4.0 | 184.9 | 10.20 |
| 2026-03-05 | STE | 238.40 | 4.0 | 164.8 | 10.20 |
| 2026-03-06 | STE | 230.49 | 4.0 | 149.2 | 10.20 |
| 2026-03-09 | STE | 227.74 | 4.0 | 172.8 | 10.20 |
| 2026-03-10 | STE | 222.11 | 4.0 | 158.8 | 10.20 |
| 2026-03-11 | STE | 221.62 | 4.0 | 183.8 | 10.20 |
| 2026-03-12 | STE | 212.33 | 4.0 | 140.1 | 10.20 |
| 2026-03-13 | STE | 214.83 | 4.0 | 199.0 | 10.20 |
| 2026-03-17 | STE | 220.13 | 4.0 | 191.6 | 10.20 |
| 2026-03-18 | STE | 216.18 | 4.0 | 166.3 | 10.20 |
| 2026-03-19 | STE | 217.94 | 4.0 | 194.9 | 10.20 |
| 2026-03-20 | STE | 220.03 | 4.0 | 196.9 | 10.20 |
| 2026-03-23 | STE | 221.09 | 4.0 | 191.4 | 10.20 |
| 2026-03-24 | STE | 221.73 | 4.0 | 189.8 | 10.20 |
| 2026-03-25 | STE | 223.46 | 4.0 | 194.7 | 10.20 |
| 2026-03-26 | STE | 223.34 | 4.0 | 185.9 | 10.20 |
| 2026-03-27 | STE | 219.42 | 4.0 | 166.2 | 10.20 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | STE | -7.22 | -2.02 | 1.85 |
| 2026-03-02 | STE | -7.22 | -0.02 | 1.85 |
| 2026-03-03 | STE | -7.22 | -0.02 | 1.85 |
| 2026-03-04 | STE | -7.22 | -0.02 | 1.85 |
| 2026-03-05 | STE | -7.22 | -0.02 | 1.85 |
| 2026-03-06 | STE | -8.04 | -0.02 | 1.85 |
| 2026-03-09 | STE | -8.04 | -0.01 | 1.85 |
| 2026-03-10 | STE | -8.04 | -0.01 | 1.85 |
| 2026-03-11 | STE | -8.04 | -0.01 | 1.78 |
| 2026-03-12 | STE | -8.04 | -0.01 | 1.78 |
| 2026-03-13 | STE | -8.04 | -0.01 | 1.78 |
| 2026-03-17 | STE | -8.04 | -0.01 | 1.78 |
| 2026-03-18 | STE | -8.04 | -0.01 | 1.78 |
| 2026-03-19 | STE | -8.04 | -0.01 | 1.78 |
| 2026-03-20 | STE | -8.04 | -0.01 | 1.78 |
| 2026-03-23 | STE | -8.04 | 0.00 | 1.78 |
| 2026-03-24 | STE | -8.04 | 0.00 | 1.78 |
| 2026-03-25 | STE | -8.04 | 0.00 | 1.80 |
| 2026-03-26 | STE | -8.04 | 0.00 | 1.80 |
| 2026-03-27 | STE | -8.04 | 0.00 | 1.80 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.53
Avg. EPS Est. Current Quarter
2.85
Avg. EPS Est. Next Quarter
2.51
Insider Transactions
-8.04
Institutional Transactions
Beta
1.07
Average Sales Estimate Current Quarter
1595
Average Sales Estimate Next Quarter
1484
Fair Value
258.27
Quality Score
87
Growth Score
90
Sentiment Score
94
Actual DrawDown %
18.6
Max Drawdown 5-Year %
-36.2
Target Price
287.33
P/E
30.35
Forward P/E
19.76
PEG
2.07
P/S
3.69
P/B
3.01
P/Free Cash Flow
23.46
EPS
7.23
Average EPS Est. Cur. Y
10.2
EPS Next Y. (Est.)
11.1
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
12.25
Relative Volume
1.05
Return on Equity vs Sector %
-17.5
Return on Equity vs Industry %
-1.9
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
166.2
◆
STE
Healthcare
$219.40
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
36.1
Range 1M
25.5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
9.3%
EPS NY
8.9%
52W%
24.2%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+17.2% upside
Upside
+17.2%
Quality
87
MoS
18%
STERIS plc (Ireland)Sector: Healthcare
Industry: Medical Devices
Employees: 17787
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
STE
Latest News
—
Caricamento notizie per STE…
stock quote shares STE – Steris Plc Stock Price stock today
news today STE – Steris Plc stock forecast ,stock prediction 2023 2024 2025
marketwatch STE – Steris Plc yahoo finance google finance
stock history STE – Steris Plc invest stock market
stock prices STE premarket after hours
ticker STE fair value insiders trading